Co-Executive Chairman & CEO, Golden State Warriors; Partner, Kleiner Perkins Caufield & Byers
Joe Lacob joined Kleiner Perkins Caufield & Byers in 1989 and established a successful investing record across multiple disciplines. He has been closely involved with KPCB’s investments in more than 50 life science companies, including the startup or incubation of a dozen ventures, and with KPCB’s medical technology practice, which includes more than 30 therapeutic and diagnostic medical device companies. Joe was also an active investing partner in KPCB’s online company initiative; he led the firm’s investment in AutoTrader.com and Sportsline. He also focused on energy investments as part of KPCB’s initiative in the fields of greentech and alternative energy. Investments include GloriOil, in microbial enhanced oil recovery, and SunDrop Fuels, a company turning biomass and natural gas into clean, cost-effective liquid transportation fuels. Joe serves on the board of directors of one public company, Align Technology, as well as several privately held companies, including NeuroPace and TransMedics.
In 2011, Joe achieved a lifelong dream by acquiring The Golden State Warriors of the NBA and became the Managing Partner and CEO of the Warriors.
Joe is also actively involved in a number of industry organizations, including the American Heart Association and the AHA Roundtable. He is also actively involved at Stanford University, where he serves on advisory boards at the Medical Center, the Business School and the Athletic Department.
Joe received his bachelor’s degree in Biological Sciences from the University of California, Irvine, his master’s degree in Public Health from the University of California, Los Angeles, and his M.B.A. from the Stanford Graduate School of Business.